J.W. Cole Advisors’s Matinas BioPharma MTNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-215
| Closed | -$1.7K | – | 955 |
|
|
2024
Q2 | $1.7K | Hold |
215
| – | – | ﹤0.01% | 889 |
|
|
2024
Q1 | $2.91K | Hold |
215
| – | – | ﹤0.01% | 880 |
|
|
2023
Q4 | $2.33K | Hold |
215
| – | – | ﹤0.01% | 815 |
|
|
2023
Q3 | $1.4K | Hold |
215
| – | – | ﹤0.01% | 734 |
|
|
2023
Q2 | $3.87K | Hold |
215
| – | – | ﹤0.01% | 756 |
|
|
2023
Q1 | $5.05K | Hold |
215
| – | – | ﹤0.01% | 774 |
|
|
2022
Q4 | $5.38K | Hold |
215
| – | – | ﹤0.01% | 741 |
|
|
2022
Q3 | $7K | Hold |
215
| – | – | ﹤0.01% | 725 |
|
|
2022
Q2 | $8K | Hold |
215
| – | – | ﹤0.01% | 733 |
|
|
2022
Q1 | $9K | Hold |
215
| – | – | ﹤0.01% | 805 |
|
|
2021
Q4 | $11K | Hold |
215
| – | – | ﹤0.01% | 832 |
|
|
2021
Q3 | $14K | Hold |
215
| – | – | ﹤0.01% | 473 |
|
|
2021
Q2 | $8K | Hold |
215
| – | – | ﹤0.01% | 736 |
|
|
2021
Q1 | $11K | Buy |
+215
| New | +$11K | ﹤0.01% | 668 |
|